XOMA logo

XOMA ROYALTY CORPORATION

XOMANASDAQ
🏆 #2727 by market capUS Equity
$717.27▼ $15.42 (−2.15%)
Simulated price
🔔
Track XOMA
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 2.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$710M
Small Cap
📈Revenue Growth (YoY)
+13.2%
Healthy
📊Gross Margin
100.0%
High
💵FCF Margin
25.9%
Strong
⚖️P/S Ratio
14.6x
Expensive
Otter Score
60
Fair
No chart data available for XOMA.

Trading Snapshot

Day Range
$706.28 – $720.24
52-Week Range
$22.29 – $45.22
Volume
$2.13B
Avg Volume
$2.25B
Shares Outstanding
17.7M
Next Earnings
Oct 27, 2026

Fundamentals Snapshot

Annual Revenue
$52M
Last Q Revenue
$12M
P/E Ratio
21.0
P/S Ratio
14.6x
EPS (TTM)
$2.00
Dividend Yield
0.78%
Dilution (1yr)
+52.7%

Why Investors Own XOMA

  • ✓High-growth profile — revenue up +57.1% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 28% gross margin and 6% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

XOMA logo

XOMA ROYALTY CORPORATION

XOMA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$52M▲ +83.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
94.3%▼ −5.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$11M▼ −128.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$3M▼ −120.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
18.1M▲ +52.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$49M▼ −$31M YoY
StockOtter · stockotter.space

About XOMA ROYALTY CORPORATION

XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and milestone payments, associated with pre-market therapeutic candidates that have already been licensed to pharmaceutical or biotechnology firms. The firm focuses its investments on early to mid-stage clinical assets, typically those in Phase 1 and 2 trials, selected for their robust commercial potential and because they are licensed to development partners. Its extensive portfolio currently encompasses around 70 distinct assets. The parent company, XOMA Corporation, established in 1981, has its main office in Emeryville, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100

Analyst Price Target

ⓘ
Average Target
$844.01
▲ +17.7% Upside
High Target$1,016.52
Low Target$692.19
Based on 31 analysts

Latest News & Updates

🚀
CNBC·2h ago

XOMA ROYALTY CORPORATION tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift XOMA price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

XOMA ROYALTY CORPORATION announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.